SEC Filing Details

Together with patients, physicians, scientists, and industry partners we are relentlessly focused on rewriting cancer so that a diagnosis is transformed from a foregone conclusion to a more hopeful future

SEC Filing Details

Document Details

Form
Filing Date
Nov 13, 2013
Document Date
Sep 30, 2013
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
Five Prime Therapeutics
Issuer
FIVE PRIME THERAPEUTICS, INC.